Haleon PLC Sponsored ADR $HLN Stock Holdings Increased by US Bancorp DE

US Bancorp DE raised its holdings in shares of Haleon PLC Sponsored ADR (NYSE:HLN) by 5.5% during the 2nd quarter, Holdings Channel reports. The fund owned 749,052 shares of the company’s stock after purchasing an additional 39,235 shares during the period. US Bancorp DE’s holdings in Haleon were worth $7,768,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently added to or reduced their stakes in HLN. Hanson & Doremus Investment Management raised its stake in Haleon by 234.1% during the 2nd quarter. Hanson & Doremus Investment Management now owns 2,372 shares of the company’s stock valued at $25,000 after acquiring an additional 1,662 shares in the last quarter. Bartlett & CO. Wealth Management LLC increased its position in shares of Haleon by 135.9% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 2,588 shares of the company’s stock valued at $27,000 after purchasing an additional 1,491 shares during the period. Banque Transatlantique SA acquired a new position in shares of Haleon during the 1st quarter valued at $27,000. Opal Wealth Advisors LLC acquired a new position in shares of Haleon during the 1st quarter valued at $29,000. Finally, Ransom Advisory Ltd acquired a new position in shares of Haleon during the 1st quarter valued at $31,000. Institutional investors own 6.67% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently issued reports on HLN. Weiss Ratings reiterated a “hold (c)” rating on shares of Haleon in a research report on Wednesday, October 8th. Barclays cut Haleon from an “overweight” rating to an “equal weight” rating in a research report on Tuesday, September 16th. The Goldman Sachs Group upgraded Haleon from a “neutral” rating to a “buy” rating in a research report on Wednesday, September 10th. Finally, Wall Street Zen cut Haleon from a “buy” rating to a “hold” rating in a research report on Saturday, July 12th. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and six have issued a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $12.33.

Haleon Stock Performance

Shares of NYSE HLN opened at $8.99 on Monday. The company has a quick ratio of 0.63, a current ratio of 0.87 and a debt-to-equity ratio of 0.48. The stock has a market capitalization of $40.01 billion, a price-to-earnings ratio of 23.04, a PEG ratio of 2.64 and a beta of 0.20. The stock’s fifty day simple moving average is $9.42 and its 200 day simple moving average is $10.02. Haleon PLC Sponsored ADR has a 52-week low of $8.71 and a 52-week high of $11.42.

Haleon Increases Dividend

The business also recently announced a semi-annual dividend, which was paid on Thursday, September 18th. Investors of record on Friday, August 15th were issued a $0.0555 dividend. This represents a dividend yield of 190.0%. The ex-dividend date was Friday, August 15th. This is a positive change from Haleon’s previous semi-annual dividend of $0.05. Haleon’s payout ratio is presently 28.21%.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.